30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma

• Arnab Basu,
• Eddy Yang,
• Yash Suri,
• Lakshminarayan Nandagopal,
• Mollie Deshazo,
• Lyse Norian

Affiliations

Arnab Basu

1University of Alabama at Birmingham, Birmingham, AL, USA

Eddy Yang

Aff1 grid.265892.20000000106344187University of Alabama at Birmingham Birmingham AL USA

Yash Suri

1University of Alabama at Birmingham, Birmingham, AL, USA

Lakshminarayan Nandagopal

1University of Alabama at Birmingham, Birmingham, AL, USA

Mollie Deshazo

1University of Alabama at Birmingham, Birmingham, AL, USA

Lyse Norian

1University of Alabama at Birmingham, Birmingham, AL, USA